ATC Group: N03AG Fatty acid derivatives

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N03AG in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N03 Antiepileptics
3 N03A Antiepileptics
4 N03AG Fatty acid derivatives

Group N03AG contents

Code Title
N03AG01 Valproic acid
N03AG02 Valpromide
N03AG03 Aminobutyric acid
N03AG04 Vigabatrin
N03AG05 Progabide
N03AG06 Tiagabine

Active ingredients in N03AG

Active Ingredient

Tiagabine is an anti-epileptic drug. Tiagabine is a potent and selective inhibitor of both neuronal and glial GABA uptake, which results in an increase in GABAergic medicated inhibition in the brain.

Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA.

Vigabatrin is a selective irreversible inhibitor of GABA transaminase, the enzyme responsible for the breakdown of GABA (gamma aminobutyric acid). Vigabatrin increases the concentration of GABA, the major inhibitory neurotransmitter in the brain.

Related product monographs

Document Type Information Source  
 CONVULEX Gastro-resistant capsule MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 DEPAKENE Oral solution MPI, CA: SPM Health Products and Food Branch (CA)
 DEPAKINE CHRONO Prolonged-release tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 EPILIM CHRONOSPHERE Modified release granules MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 EPILIM Powder and solvent for solution for injection / infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 EPIVAL Prolonged-release tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 GABITRIL Film-coated tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 KIGABEQ Soluble tablet MPI, EU: SmPC European Medicines Agency (EU)
 RUBILIM Prolonged release tablet MPI, Generic Health Products Regulatory Authority (ZA)
 SABRIL Film-coated tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 VIGAFYDE Oral solution MPI, US: SPL/PLR